Multicell's Library of New Biopharma Ideas
No ratings
Although I specifically try to avoid writing in a casual 'first person' for the SmallCap Digest, I'm willing to make an exception this time. After all, it is a weekend edition, and time to relax, right? Besides, it's much easier to make point when the bar